Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs

Cardiovascular Research

Volumn 31, Issue 5, 1996, Pages 711-718

  Vander Heide, Richard S ^a,b   Reimer, Keith A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine; Lidocaine; Myocardial infarct size; Myocardial ischemia; Reperfusion

Indexed keywords

ADENOSINE; LIDOCAINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ADENOSINE; ANIMALS; DOGS; FEMALE; LIDOCAINE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM;

EID: 0029929116     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(95)00235-9     Document Type: Article

References (29)

1. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 1987; 84:1404-1407.
2. Zweier JL, Rayburn BK, Flaherty JT, Weisfeldt ML. Recombinant superoxide dismutase reduces oxygen free radical concentrations in reperfused myocardium. J Clin Invest 1987;80:1728-1734.
3. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB. Demonstration of free radical generation in 'stunned' myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest 1988;82:476-485.
4. Lucchesi BR, Mullane KM. Leukocytes and ischemia-induced injury. Ann Rev Pharmacol Toxicol 1986;26:201-224.
5. Simpson PJ, Todd RF III, Mickelson JK, et al. Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function. Circulation 1990;81:226-237.
6. Simpson PJ, Mickelson JK, Fantone JC, Gallagher KP, Lucchesi BR. Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart. Circ Res 1987;69:666-673.
7. Simpson PJ, Todd RF III, Fantone JC, Mickelson JK, Griffin JD, Lucchesi BR. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti Mol, anti CD11b) that inhibits leukocyte adhesion. J Clin Invest 1988;81:624-629.
8. Simpson PJ, Mickelson JK, Fantone JC, Gallagher KP, Lucchesi BR. Reduction of experimental canine myocardial infarct size with prostaglandin E1. Inhibition of neutrophil migration and activation. J Pharmacol Exp Ther 1988;244:619-624.
9. 2-receptor activation at reperfusion reduces infarct size and improves myocardial wall function in dog heart. J Cardiovasc Pharmacol 1993;22:89-96.
10. Reimer KA, Jennings RB. Failure of the xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs. Circulation 1985;71:1069-1075.
11. Uraizee A, Reimer KA, Murry CE, Jennings RB. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs. Circulation 1987;75:1237-1248.
12. Nejima J, Knight DR, Fallon JT, et al. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function of myocardium at risk in conscious dogs. Circulation 1989;79:143-153.
13. Patel BS, Jeroudi MO, O'Neill PG, Roberts R, Bolli R. Human superoxide dismutase fails to limit infarct size after 2-h ischemia and reperfusion. Circulation 1988;78:II-373 (Abstract).
14. Go LO, Murry CE, Richard VJ, Jennings RB, Reimer KA. Neutrophil accumulation during early myocardial reperfusion: 40 vs. 90 minutes of ischemia. Circulation 1987;76(4):202 (Abstract).
15. Tanaka M, Brooks SE, Richard VJ, et al. Effect of anti-CD18 antibody on myocardial neutrophil accumulation and infarct size after 90 minutes of ischemia and 3 hours of reperfusion in dogs. Circulation 1993;87:526-535.
16. Ganz W, Watanabe I, Kanamasa K, Yano J, Han D-S, Fishbein MC. Does reperfusion extend necrosis? A study in a single territory of myocardial ischemia - half reperfused and half not reperfused. Circulation 1990;82:1020-1033
17. Olafsson B, Forman MB, Puett DW, et al. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and no-reflow phenomenon. Circulation 1987;76:1135-1145.
18. Homeister JW, Hoff PT, Fletcher DD, Lucchesi BR. Combined adenosine and lidocaine administration limits myocardial reperfusion injury. Circulation 1990;82:595-608.
19. Pitarys CJ, Virmani R, Vildibill HD Jr, Jackson EK, Forman MB. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. Circulation 1991;83:237-247.
20. Nichols WW, Nicolini FA, Yang BC, Henson K, Stechmiller JK, Mehta JL. Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion. Am Heart J 1994;127:1201-1211.
21. Goto M, Miura T, Iliodoromitis K, et al. Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species. Cardiovasc Res 1991;25:943-949.
22. Tanaka M, Richard VJ, Murry CE, Jennings RB, Reimer KA. Superoxide dismutase plus catalase therapy delays neither cell death nor the loss of the TTC reaction in experimental myocardial infarction in dogs. J Mol Cell Cardiol 1993;25:367-378.
23. Chien GL, Wolff RA, Davis RF, Van Winkle DM: Normothermic range temperature affects myocardial infarct size. Cardiovasc Res 1994;28:1014-1017.
24. Verbinski SG, Schwartz LM, Vander Heide RS, Reimer KA. Minor variation in pericardial temperature is a major predictor of infarct size in dogs. Circulation 1995;92:1-457 (Abstract).
25. Anderson K, Walker R, Lux R, et al. Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effect of lidocaine in the intact canine heart. Circulation 1990;81:1024-1038.
26. Patterson E, Gibson J, Lucchesi B. Electrophysiologic actions of lidocaine in a canine model of chronic myocardial ischemic damage - arrhythmogenic actions of lidocaine. J Cardiovasc Pharmacol 1982;4:925-934.
27. Patterson E, Gibson J, Lucchesi B. Antiarrhythmic and arrhythmogenic actions of methyl lidocaine during the recovery phase after canine myocardial infarction. Pharmacology 1988;36:73-83.
28. Carson D, Cardinal R, Savard P, et al. Relationship between arrhythmogenic action of lidocaine and its effects on excitation patterns in acutely ischemic porcine myocardium. J Cardiovasc Pharmacol 1986;8:126-136.
29. Bergey J, Nocella K, McCallum J. Acute coronary artery occlusion-reperfusion-induced arrhythmias in rats, dogs and pigs: antiarrhythmic evaluation of quinidine, procainamide and lidocaine. Eur J Pharmacol 1982;81:205-216.